" /> Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1 - CISMeF





Preferred Label : Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1;

Symbol : MDDGC1;

CISMeF acronym : LGMD2K; MDDGC1; LGMDR11;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Muscular dystrophy, limb-girdle, type 2k; LGMD2K; Muscular dystrophy, limb-girdle, autosomal recessive 11; LGMDR11;

Description : Limb-girdle muscular dystrophies resulting from defective glycosylation of alpha-dystroglycan (DAG1; 128230) represent the mildest end of the phenotypic spectrum of muscular dystrophies collectively known as dystroglycanopathies. The limb-girdle phenotype is characterized by onset of muscular weakness apparent after ambulation is achieved; mental retardation and mild brain anomalies are variable (Balci et al., 2005; review by Godfrey et al., 2007). The most severe end of the phenotypic spectrum of dystroglycanopathies is represented by congenital muscular dystrophy-dystroglycanopathy with brain and eye anomalies (type A; see;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the protein O-mannosyltransferase-1 gene (POMT1, 607423.0005);

Laboratory abnormalities : Increased serum creatine kinase;

Prefixed ID : #609308;

Details


You can consult :


Nous contacter.
02/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.